Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081)

( DrugBank: Caplacizumab, Von willebrand factor / KEGG DRUG: Caplacizumab )


1 disease
IDDisease name (Link within this page)Number of trials
64Thrombotic thrombocytopenic purpura10

64. Thrombotic thrombocytopenic purpura


Clinical trials : 92Drugs : 85 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 76